Mithra Pharmaceuticals S.A.（MITPF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · MITPF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2023-12	2022-12	2021-12	2020-12	2019-12
Revenue
Revenue	$40.16M	$67.00M	$22.67M	$9.03M	$96.52M
Cost of Revenue	$34.16M	$31.56M	$26.15M	$13.33M	$8.26M
Gross Profit	$5.99M	$35.43M	($3.48M)	($4.30M)	$88.26M
Gross Margin %(computed)	14.92%	52.89%	-15.36%	-47.62%	91.44%
Operating Expenses
R&D Expenses	$63.17M	$64.04M	$85.24M	$78.46M	$57.07M
G&A Expenses	$22.09M	$14.68M	$12.52M	$15.93M	$14.77M
Total Operating Expenses	$75.31M	$68.88M	$89.20M	$85.95M	$67.84M
Operating Income	($69.32M)	($33.44M)	($92.69M)	($90.25M)	$20.42M
Operating Margin %(computed)	-172.63%	-49.92%	-408.88%	-999.48%	21.15%
Interest Income	$1.75M	$14.03M	$11.77M	$3.50M	$3.32M
Interest Expense	$22.90M	$17.03M	$12.12M	$3.56M	$3.37M
Income Before Tax	($161.79M)	($13.56M)	($126.34M)	($112.79M)	($33.01M)
Income Tax Expense	$11.71M	$46.06M	($9.46M)	($20.70M)	($6.45M)
Net Income	($173.50M)	($59.62M)	($116.88M)	($92.09M)	($26.56M)
Net Margin %(computed)	-432.08%	-88.99%	-515.59%	—	-27.52%
Per Share & EBITDA
EPS (Basic)	$-2.51	$-1.22	$-2.69	$-2.25	$-0.70
Wtd Avg Shares	69.12M	49.06M	43.43M	40.99M	37.75M
EBITDA	($52.77M)	$17.46M	($82.26M)	($80.38M)	$26.19M
EBITDA Margin %(computed)	-131.42%	26.06%	-362.89%	-890.14%	27.14%